BASILEA PHARMACEUTICA

Dead / Abandoned — Abandoned — no statement of use filed (as of 05 Aug 2024)

What this means for you

This application is over — abandoned 05 Aug 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
90269990
Mark type
Stylized text
Filed
21 Oct 2020
Published for opposition
04 May 2021
Abandoned
05 Aug 2024
Attorney of record
Evan A. Raynes

Goods and services

  • Class 001 — Chemicals: Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use
  • Class 005 — Pharmaceuticals: Pharmaceutical and veterinary products and preparations for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Pharmaceutical and veterinary products and preparations for the treatment and prevention of infections caused by bacteria, fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of allergy; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of anesthesiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; diagnostic preparations for medical purposes; clinical medical reagents
  • Class 042 — Scientific and technological services: Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations

Owner

Prosecution history

  • 05 Aug 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
  • 05 Aug 2024 — ABANDONMENT - NO USE STATEMENT FILED
  • 11 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 10 Jan 2024 — SOU EXTENSION 5 GRANTED
  • 19 Dec 2023 — SOU EXTENSION 5 FILED
  • 10 Jan 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 19 Dec 2023 — SOU TEAS EXTENSION RECEIVED
  • 28 Jun 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 22 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 20 Jun 2023 — SOU EXTENSION 4 GRANTED
  • 20 Jun 2023 — SOU EXTENSION 4 FILED
  • 20 Jun 2023 — SOU TEAS EXTENSION RECEIVED
  • 07 Dec 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 05 Dec 2022 — SOU EXTENSION 3 GRANTED
  • 05 Dec 2022 — SOU EXTENSION 3 FILED

View this trademark record on Marksy